Education
About Us
Working with TipRanks
Follow Us
VentriPoint Diagnostics Ltd (TSE:VPT)
:VPT
RESEARCH TOOLSreports
Total Valuation
VentriPoint Diagnostics has a market cap or net worth of C$22.51M. The enterprise value is C$37.39M.
Market CapC$22.51M
Enterprise ValueC$37.39M
Share Statistics
VentriPoint Diagnostics has 166,733,540 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding166,733,540
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
VentriPoint Diagnostics’s return on equity (ROE) is 1.65 and return on invested capital (ROIC) is 350.53%.
Return on Equity (ROE)1.65
Return on Assets (ROA)-7.48
Return on Invested Capital (ROIC)350.53%
Return on Capital Employed (ROCE)1.73
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.14
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of VentriPoint Diagnostics is -3.22. VentriPoint Diagnostics’s PEG ratio is -0.91.
PE Ratio-3.22
PS Ratio0.00
PB Ratio9.25
Price to Fair Value-5.31
Price to FCF-10.18
Price to Operating Cash Flow-10.18
PEG Ratio-0.91
Income Statement
In the last 12 months, VentriPoint Diagnostics had revenue of 95.17K and earned -4.92M in profits. Earnings per share was -0.03.
Revenue95.17K
Gross Profit95.17K
Operating Income-4.80M
Pretax Income-5.00M
Net Income-4.92M
EBITDA-4.76M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -3.39M and capital expenditures -4.00, giving a free cash flow of -3.39M billion.
Operating Cash Flow-3.39M
Free Cash Flow-3.39M
Free Cash Flow per Share-0.02
Dividends & Yields
VentriPoint Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.03
52-Week Price Change-35.00%
50-Day Moving Average0.13
200-Day Moving Average0.13
Relative Strength Index (RSI)48.78
Average Volume (3m)177.80K
Important Dates
VentriPoint Diagnostics upcoming earnings date is Aug 27, 2025, Before Open (Confirmed).
Last Earnings DateMay 30, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
VentriPoint Diagnostics as a current ratio of 0.14, with Debt / Equity ratio of 10.08%
Current Ratio0.14
Quick Ratio0.14
Debt to Market Cap0.09
Net Debt to EBITDA-0.33
Interest Coverage Ratio-26.72
Taxes
In the past 12 months, VentriPoint Diagnostics has paid -83.47K in taxes.
Income Tax-83.47K
Effective Tax Rate0.02
Enterprise Valuation
VentriPoint Diagnostics EV to EBITDA ratio is -3.66, with an EV/FCF ratio of -5.14.
EV to Sales182.85
EV to EBITDA-3.66
EV to Free Cash Flow-5.14
EV to Operating Cash Flow-5.14
Balance Sheet
VentriPoint Diagnostics has C$60.55K in cash and marketable securities with C$1.63M in debt, giving a net cash position of C$1.57M billion.
Cash & Marketable SecuritiesC$60.55K
Total DebtC$1.63M
Net CashC$1.57M
Net Cash Per Share<C$0.01
Tangible Book Value Per Share-C$0.02
Margins
Gross margin is 84.80%, with operating margin of -5045.41%, and net profit margin of -5169.14%.
Gross Margin84.80%
Operating Margin-5045.41%
Pretax Margin-5256.85%
Net Profit Margin-5169.14%
EBITDA Margin-5001.96%
EBIT Margin-5068.02%
Analyst Forecast
The average price target for VentriPoint Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast280.56%
EPS Growth Forecast-7.28%